Synlogic presents data on hyperoxaluria program at american society of nephrology kidney week 2021

Cambridge, mass., oct. 15, 2021 /prnewswire/ -- synlogic, inc. (nasdaq: sybx), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced two poster presentations at the upcoming american society for nephrology (asn) kidney week 2021, to be held virtually november 4 – 7th, 2021.

SYBX Ratings Summary

SYBX Quant Ranking